This seems to be related to the development of low levels of insulin derivatives in the late stages of manufacturing, and storage of insulin thereafter.14 Furthermore, many people with diabetes, especially T1DM, have detectable levels of insulin antibodies as part of the pathological process of the condition, even before they receive insulin products.15 This evidence concerns the gene INS and type 1 diabetes mellitus.